Goldstein Dov A Md - Net Worth and Insider Trading
Goldstein Dov A Md Net Worth
The estimated net worth of Goldstein Dov A Md is at least $2 Million dollars as of 2024-04-24. Goldstein Dov A Md is the Director of Esperion Therapeutics Inc and owns about 837,125 shares of Esperion Therapeutics Inc (ESPR) stock worth over $2 Million. Goldstein Dov A Md is the Director of Coya Therapeutics Inc and owns about 10,000 shares of Coya Therapeutics Inc (COYA) stock worth over $84,100. Goldstein Dov A Md is also the Director of NeuBase Therapeutics Inc and owns about 10,000 shares of NeuBase Therapeutics Inc (NBSE) stock worth over $4,210. Details can be seen in Goldstein Dov A Md's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Goldstein Dov A Md has not made any transactions after 2023-01-03 and currently still holds the listed stock(s).
Transaction Summary of Goldstein Dov A Md
Goldstein Dov A Md Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Goldstein Dov A Md owns 7 companies in total, including NeuBase Therapeutics Inc (NBSE) , ADMA Biologics Inc (ADMA) , and Esperion Therapeutics Inc (ESPR) among others .
Click here to see the complete history of Goldstein Dov A Md’s form 4 insider trades.
Insider Ownership Summary of Goldstein Dov A Md
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NBSE | NeuBase Therapeutics Inc | 2020-04-30 | director |
| ADMA | ADMA Biologics Inc | 2012-02-13 | director |
| ESPR | Esperion Therapeutics Inc | 2017-03-22 | director |
| MLNTQ | Melinta Therapeutics Inc | 2017-03-07 | director |
| LOXO | Loxo Oncology Inc | 2015-04-01 | 10 percent owner & CFO and Treasurer |
| GANX | Gain Therapeutics Inc | 2021-03-17 | director |
| COYA | Coya Therapeutics Inc | 2023-01-03 | director |
Goldstein Dov A Md Latest Holdings Summary
Goldstein Dov A Md currently owns a total of 3 stocks. Among these stocks, Goldstein Dov A Md owns 837,125 shares of Esperion Therapeutics Inc (ESPR) as of March 22, 2017, with a value of $2 Million and a weighting of 95.28%. Goldstein Dov A Md owns 10,000 shares of Coya Therapeutics Inc (COYA) as of January 3, 2023, with a value of $84,100 and a weighting of 4.49%. Goldstein Dov A Md also owns 10,000 shares of NeuBase Therapeutics Inc (NBSE) as of April 30, 2020, with a value of $4,210 and a weighting of 0.22%.
Latest Holdings of Goldstein Dov A Md
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ESPR | Esperion Therapeutics Inc | 2017-03-22 | 837,125 | 2.13 | 1,783,076 |
| COYA | Coya Therapeutics Inc | 2023-01-03 | 10,000 | 8.41 | 84,100 |
| NBSE | NeuBase Therapeutics Inc | 2020-04-30 | 10,000 | 0.42 | 4,210 |
Holding Weightings of Goldstein Dov A Md
Goldstein Dov A Md Form 4 Trading Tracker
According to the SEC Form 4 filings, Goldstein Dov A Md has made a total of 0 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years. The most-recent trade in Esperion Therapeutics Inc is the sale of 800,000 shares on March 22, 2017, which brought Goldstein Dov A Md around $33 Million.
According to the SEC Form 4 filings, Goldstein Dov A Md has made a total of 1 transactions in Coya Therapeutics Inc (COYA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Coya Therapeutics Inc is the acquisition of 10,000 shares on January 3, 2023, which cost Goldstein Dov A Md around $46,500.
According to the SEC Form 4 filings, Goldstein Dov A Md has made a total of 1 transactions in NeuBase Therapeutics Inc (NBSE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in NeuBase Therapeutics Inc is the acquisition of 10,000 shares on April 30, 2020, which cost Goldstein Dov A Md around $60,000.
Insider Trading History of Goldstein Dov A Md
- 1
Goldstein Dov A Md Trading Performance
GuruFocus tracks the stock performance after each of Goldstein Dov A Md's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Goldstein Dov A Md is 8.84%. GuruFocus also compares Goldstein Dov A Md's trading performance to market benchmark return within the same time period. The performance of stocks bought by Goldstein Dov A Md within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Goldstein Dov A Md's insider trading performs compared to the benchmark.
Performance of Goldstein Dov A Md
Average Return
13.61%
Outperforming Transactions
67%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.19 | 8.84 | -3.51 | 13.61 | 40.52 | -41.78 |
| Relative Return to S&P 500(%) | -0.94 | 0.75 | -17.92 | -15.99 | 24.24 | -52.74 |
Goldstein Dov A Md Ownership Network
Ownership Network List of Goldstein Dov A Md
Ownership Network Relation of Goldstein Dov A Md
Goldstein Dov A Md Owned Company Details
What does NeuBase Therapeutics Inc do?
Who are the key executives at NeuBase Therapeutics Inc?
Goldstein Dov A Md is the director of NeuBase Therapeutics Inc. Other key executives at NeuBase Therapeutics Inc include 10 percent owner Symetryx Corp , 10 percent owner Barry Shiff , and 10 percent owner Aleta Shiff .
NeuBase Therapeutics Inc (NBSE) Insider Trades Summary
Over the past 18 months, Goldstein Dov A Md made no insider transaction in NeuBase Therapeutics Inc (NBSE). Other recent insider transactions involving NeuBase Therapeutics Inc (NBSE) include a net sale of 428,444 shares made by Symetryx Corp ,
In summary, during the past 3 months, insiders sold 0 shares of NeuBase Therapeutics Inc (NBSE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 489,520 shares of NeuBase Therapeutics Inc (NBSE) were sold and 61,076 shares were bought by its insiders, resulting in a net sale of 428,444 shares.
NeuBase Therapeutics Inc (NBSE)'s detailed insider trading history can be found in Insider Trading Tracker table.
NeuBase Therapeutics Inc Insider Transactions
Goldstein Dov A Md Mailing Address
Above is the net worth, insider trading, and ownership report for Goldstein Dov A Md. Currently GuruFocus does not have mailing address information for Goldstein Dov A Md.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
